Position in CPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,573,001
+$6,441,079 QoQ
Shares Held
346,244
+279.1% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. CPRX ranks #38 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in CPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,573,001 | 346,244 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,131,922 | 91,342 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,647,258 | 185,140 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,559,476 | 302,280 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,872,525 | 242,166 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $46,620,115 | 2,233,834 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $48,287,983 | 2,428,973 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $38,305,732 | 2,472,933 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,571,883 | 224,083 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,678,394 | 99,845 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,103,173 | 94,369 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,208,769 | 164,343 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $3,114,291 | 167,435 | Shares | Sole | 2023-02-09 | |
| 2022-06-30 | $999,829 | 142,629 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,218,886 | 147,031 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,053,181 | 155,566 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $721,637 | 136,158 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,403,356 | 244,062 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $1,168,925 | 253,563 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $778,921 | 233,210 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $722,648 | 243,316 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||